p53	0	3	B-Gene_or_gene_product
hot	4	7	O
-	7	8	O
spot	8	12	O
mutants	13	20	O
increase	21	29	O
tumor	30	35	B-Pathological_formation
vascularization	36	51	O
via	52	55	O
ROS	56	59	B-Drug_or_compound
-	59	60	O
mediated	60	68	O
activation	69	79	O
of	80	82	O
the	83	86	O
HIF1	87	91	B-Gene_or_gene_product
/	91	92	O
VEGF	92	96	B-Gene_or_gene_product
-	96	97	I-Gene_or_gene_product
A	97	98	I-Gene_or_gene_product
pathway	99	106	O
.	106	107	O

The	109	112	O
function	113	121	O
of	122	124	O
p53	125	128	B-Gene_or_gene_product
tumor	129	134	B-Pathological_formation
suppressor	135	145	O
is	146	148	O
often	149	154	O
altered	155	162	O
in	163	165	O
various	166	173	O
human	174	179	B-Organism
tumors	180	186	B-Pathological_formation
predominantly	187	200	O
through	201	208	O
missense	209	217	O
-	217	218	O
mutations	218	227	O
resulting	228	237	O
in	238	240	O
accumulation	241	253	O
of	254	256	O
mutant	257	263	O
proteins	264	272	O
.	272	273	O

We	274	276	O
revealed	277	285	O
that	286	290	O
expression	291	301	O
of	302	304	O
p53	305	308	B-Gene_or_gene_product
proteins	309	317	O
with	318	322	O
amino	323	328	O
-	328	329	O
acid	329	333	O
substitutions	334	347	O
at	348	350	O
codons	351	357	O
175	358	361	O
(	362	363	O
R175H	363	368	O
)	368	369	O
,	369	370	O
248	371	374	O
(	375	376	O
R248W	376	381	O
)	381	382	O
,	382	383	O
and	384	387	O
273	388	391	O
(	392	393	O
R273H	393	398	O
)	398	399	O
,	399	400	O
representing	401	413	O
the	414	417	O
hot	418	421	O
-	421	422	O
spots	422	427	O
of	428	430	O
mutations	431	440	O
in	441	443	O
various	444	451	O
human	452	457	B-Organism
tumors	458	464	B-Pathological_formation
,	464	465	O
increased	466	475	O
the	476	479	O
number	480	486	O
of	487	489	O
vessels	490	497	B-Multi-tissue_structure
in	498	500	O
HCT116	501	507	B-Pathological_formation
human	508	513	I-Pathological_formation
colon	514	519	I-Pathological_formation
carcinoma	520	529	I-Pathological_formation
xenografts	530	540	I-Pathological_formation
and	541	544	O
,	544	545	O
as	546	548	O
a	549	550	O
result	551	557	O
,	557	558	O
accelerated	559	570	O
their	571	576	O
growth	577	583	O
.	583	584	O

Stimulation	585	596	O
of	597	599	O
tumor	600	605	B-Pathological_formation
angiogenesis	606	618	O
was	619	622	O
connected	623	632	O
with	633	637	O
about	638	643	O
2	644	645	O
-	645	646	O
fold	646	650	O
increase	651	659	O
in	660	662	O
intracellular	663	676	O
level	677	682	O
of	683	685	O
reactive	686	694	B-Drug_or_compound
oxygen	695	701	I-Drug_or_compound
species	702	709	I-Drug_or_compound
(	710	711	O
ROS	711	714	B-Drug_or_compound
)	714	715	O
.	715	716	O

Antioxidant	717	728	O
N	729	730	B-Drug_or_compound
-	730	731	I-Drug_or_compound
acetyl	731	737	I-Drug_or_compound
-	737	738	I-Drug_or_compound
l	738	739	I-Drug_or_compound
-	739	740	I-Drug_or_compound
aspartate	740	749	I-Drug_or_compound
(	750	751	O
NAC	751	754	B-Drug_or_compound
)	754	755	O
decreased	756	765	O
vessels	766	773	B-Multi-tissue_structure
number	774	780	O
in	781	783	O
tumors	784	790	B-Pathological_formation
formed	791	797	O
by	798	800	O
cells	801	806	B-Cell
with	807	811	O
inactivated	812	823	O
p53	824	827	B-Gene_or_gene_product
and	828	831	O
inhibited	832	841	O
their	842	847	O
growth	848	854	O
.	854	855	O

Effect	856	862	O
of	863	865	O
ROS	866	869	B-Drug_or_compound
on	870	872	O
angiogenesis	873	885	O
in	886	888	O
tumors	889	895	B-Pathological_formation
expressing	896	906	O
hot	907	910	O
-	910	911	O
spot	911	915	O
p53	916	919	B-Gene_or_gene_product
mutants	920	927	O
was	928	931	O
correlated	932	942	O
with	943	947	O
their	948	953	O
ability	954	961	O
to	962	964	O
increase	965	973	O
a	974	975	O
content	976	983	O
of	984	986	O
HIF1	987	991	B-Gene_or_gene_product
transcriptional	992	1007	O
factor	1008	1014	O
responsible	1015	1026	O
for	1027	1030	O
up	1031	1033	O
-	1033	1034	O
regulation	1034	1044	O
of	1045	1047	O
VEGF	1048	1052	B-Gene_or_gene_product
-	1052	1053	I-Gene_or_gene_product
A	1053	1054	I-Gene_or_gene_product
mRNAs	1055	1060	O
.	1060	1061	O

